UCB

Activities: Manufacturing Research & Development

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. Dot Compliance upgrades AI-powered life sciences eQMS system, Dottie AI The system utilises generative and predictive AI to streamline and optimise the quality management process for customers in the pharmaceutical, biotech and medical device...
  3. HOOKIPA Pharma begins non-binding discussions to acquire Poolbeg Pharma The two pharmaceutical companies may create a clinical-stage biopharmaceutical company focused on the development and commercialisation of next-generation immunotherapies
  4. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Ingredients

Therapeutic: rozanolixizumab for generalised myasthenia gravis

Generalised myasthenia gravis (gMG) is a rare disease with symptoms that include severe muscular weakness and which is characterised by dysfunction and damage at the neuromuscular junction
Ingredients

Therapeutic: zilucoplan for myasthenia gravis

The rare disease myasthenia gravis (MG) is an autoimmune condition that causes muscle weakness, particularly of those in the face, eyes and that control swallowing
Ingredients

Therapeutics: rozanolixizumab for primary immune thrombocytopenia

Primary immune thrombocytopenia (ITP) is a rare acquired autoimmune disorder. Most patients have pathogenic IgG autoantibodies that target platelets and their precursor megakaryocytes
Ingredients

Therapeutics: dapirolizumab for systemic lupus erythematosus

Although there have been some advances in recent years, systemic lupus erythematosus (SLE) remains a significant unmet medical need
Manufacturing

UCB Pharma chooses South Korean CDMO for the third time

Samsung Biologics will now produce UCB’s anti-tau candidate for Belgian pharma company to treat progressive supranuclear palsy
Manufacturing

Continuous manufacturing: making it real

Industry pioneers GEA, Siemens and Perceptive Engineering recently hosted the inaugural Reality of Continuous Pharmaceutical Manufacturing conference in Durham, UK, to examine the current status of going conti and present real-life applications to an international audience. Dr Kevin Robinson reports
Packaging

Pharmapack Europe 2019 reveals winners

Award winners have been selected for innovation in delivery, dosage and packaging of pharmaceutical products
Subscribe now